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ABSTRACT 
The current study focuses on the psychological effects of statin medications. 
Specifically, this study examines the health related beliefs and behaviors that may be 
altered by the consumption of this fast acting class of life saving drugs. Although the 
statin class of medication generally produces favorable physiological results, as 
evidenced by reduced levels of serum cholesterol, and in some case increases in high-
density lipoproteins, the health related belief system and heath related behaviors may 
actually be altered in a negative fashion by engendering a sense of overconfidence; this in 
tum may alter beliefs and diminish the impOliance of adhering to a healthy diet and 
active exercise schedule. Surveys were developed to solicit patient agreement along a 
five point Likeli scale. Items were constructed to assess health related beliefs, 
medication overconfidence, locus of control, and exercise habits. Sixty-four primary care 
patients from Northeastem and Southeastern Pennsylvania were randomly selected to 
complete the surveys. 
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CHAPTER 1 
INTRODUCTION 
Unfortunately, or fortunately, depending on one's perspective, the effects of a 
fast-paced, technologically advanced, and almost completely automated society have all 
but taken over the American landscape. It is a rare event to see a construction site 
without the advanced machinery preparing a foundation, factories where assembly lines 
are still dominated by humans, or an office building where the staircase is the primary 
means of conveyance to higher floors. Although the trades, business, and professional 
areas of the American economy have enjoyed considerable teclmological expansion in 
conducting everyday business and providing niceties to the working world, it appears 
there may be some health-related tradeoffs. Indeed, many of the technological 
advancements have made the workplace much safer, healthier, and more efficient for all, 
but at what point do we cross the line of balancing necessary human physical activity and 
complete automation? 
Interestingly, consumers have grown quite accustomed to receiving the benefits of 
technology, and have become quite concerned when contractors, business consultants, or 
medical professionals peliorm their trades without the use of the latest technology or 
state of the art equipment. Some argue that Americans have become so accustomed to 
expecting the latest trends in technology, best ergonomics, most sophisticated medical 
procedures, and longest acting pain relieving drugs that we may miss the opportunity to 
examine critically what these advancements actually replace, negate, or simplify. In 
short, many have become, and continue to be, quite dependent on technological and 
medical advancements to the extent that other areas of functioning may actually be 
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starting to suffer, specifically, the condition of one's physical health and mental well 
being. Has technology provided the confidence to overlook completely the simple, 
repetitive behaviors and common sense beliefs that may have prevented the onset of 
chronic medical conditions? Can dramatically increasing rates of obesity, hypertension, 
hypercholesterolemia, and diabetes be the sole effects of an almost completely automated 
and technologically advanced society? FUlihermore, have these advances in technology, 
pmiicularly in the field of medicine, encouraged a belief system consistent with 
overconfident eating habits, poorer participation in health related behaviors such as 
exercise, and shoddier health outcomes in general? Advances, including those in 
automotive technology, bio-medical science, residential engineering, medicine, surgery, 
and business, have provided the population with conveniences and necessities that 
dramatically enhance the quality of human life in many ways. Yet the long-term impact 
of technology on our health-status, behavior, and belief system celiainly appears to be an 
understudied area of concern. 
Particularly, advances in medicine and medical technology are generally seen as 
very positive contributions to humanity, and it is not the intention of this research to 
condemn or appear anti-progressive; rather, the intention is to heighten the level of 
awareness with respect to the misplaced positive health-related behaviors and beliefs, 
which may be negatively influenced as a result of the availability of medicines and 
medical technology. To illustrate this point further, and begin to frame a conceptual 
argument, it is useful to cite the convenience and speed at which fast-food restaurants 
serve their drive-thru customers during lunch, some in 90 seconds or less-guaranteed. 
Whereas this ability is certainly the product of a great technology serving the demands of 
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its culture, one needs to consider the lost or missed opportunities for a variety of simple, 
but valuable, human functions. These of course include casual socialization, a much 
needed distraction from a stressful work place, simple physical movement like walking 
through a parking lot in lieu of drive-thm, or simply having the oppOltunity to eat one's 
lunch slowly. Although disparagement is not directed at the fast-food industry, there 
does need to be a heightened awareness of current cultural demands and the impact on 
psychological and physiological health. 
Succumbing to pressures of eating while "on the go" happens to a great number of 
Americans, yet one may not recognize the ill affects that these conveniences have on the 
human body. Drawing attention to eating while making the moming commute or 
grabbing lunch between appointments may not sound like very interesting conversation 
requiring much scientific consideration; it simply is not a healthy habit. However, what 
does appear to require attention and discussion is the marketing and consumption of 
medications such as antacids, gastric acid reducers, antihypertensives, anti-anxiety, 
antidepressants, anti-cholesterol, diuretics, and sleep medications. For instance, Richter 
(1992) reported the results of a Gallup survey indicating that 44% of all adult Americans 
experience heartbum at least once every month, 10% of all adult Americans complain of 
acid reflux symptoms weekly and 40% of adult Americans took antacids for symptom 
relief; however, only one in four discuss these symptoms with their doctors. Although, 
no causal statements between poor eating habits and acid reflux are made here, the sales 
trends in medicines used to treat gastroesophageal reflux disorder (GERD) and the 
national epidemic of obesity may appear to provide an interesting correlation. Although 
the side effects that a technological and turbulent culture has on human health will remain 
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theoretically debatable, the ever present and real health-related effects continue to appear 
at an alarming rate across the United States. 
In the final review of Healthy People 2000, the Center for Disease Control and 
Prevention (CDC) reported an estimated 60 million Americans have cardiovascular 
disease (CVD) and more than 950,000 die year1y from the condition. This disease alone 
accow1ts for approximately 40 percent of all American deaths per year. The CDC also 
reports that coronary heart disease and stroke, the two primary conditions of CVD, 
account, respectively, for the first and third leading causes of deaths in Americans; 
coronary heart disease, alone, accounts for an estimated 12 million cases in the United 
States every year. In an attempt to study health problems and move toward healthier 
outcomes for Americans, the CDC has prioritized a list of health related issues and 
behaviors that currently affect Americans and have specifically developed targeted areas 
of priority regarding healthy outcomes. The first priority area targeted for improvement 
includes physical activity and fitness. Physical activity and vigorous exercise practiced 
on a routine schedule can improve the quality oflife for many, ifnot all, individuals with 
health related problems. McGuinnis and Foege (1993) report that 14 percent of all deaths 
in the United States were related to diet and activity habits; whereas, Kujala, Kaprio, 
Sal11a, and Koskenvuo (1998) conclude that leisure time physical activity is associated 
with decreased mOliality, even after genetic and other familial factors were considered. 
Additionally, the 1996 Surgeon General's report on Physical Activity and Health clearly 
indicates that physical activity has been shown to reduce the risk of developing or dying 
from heart disease, diabetes, colon cancer, or hypeliension, also indicating that physical 
activity improves mental health as well as the health of muscles, bones, and joints. Quite 
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simply, the benefits of physical activity cannot be overstated. Physical activity simply 
pays very rich dividends and yet Americans seem to be ignoring this life sustaining data. 
For example, in related findings, the CDC published an early release of selected estimates 
based on data from the 2004 National Health Interview Survey in which trends in health 
conditions and health related behaviors were compared from 1997 through 2004. In this 
report, the CDC cited an increasing trend in the prevalence of diabetes among adults ages 
18 and older from 5.1 % in 1997 to 7.0% in 2004, and an increasing trend in obesity 
among adults ages 18 and older from 19.4% in 1997 to 24.5% in 2004. Conversely, the 
CDC also reported similar longitudinal type data on health-related behaviors and beliefs, 
but with discouraging results. For example the CDC, in an early release estimate, 
reported that adults ages 18 and older who engaged in regular leisure time physical 
activity actually increased from 29.9% in 1998 to 31.9% in 2000, but did not change 
significantly from 2000 to 2003 and actually decreased from 2003 to 2004. Furthermore, 
the CDC assessed the perception of individual health status in adults ages 18 and older, 
reporting an estimated decrease in the number of adults who reported their health status 
as excellent or very good from the years 2001 (68.4%) to 2004 (66.5%). Considering 
these statistics and trends in health-related behaviors and health beliefs, and the 
increasing trends in CVD, a review is needed to identify the influence of mediating or 
moderating variables which may place undue emphasis on clinical interventions while 
minimizing the effect of exercise and healthy eating needs. A discussion of these 
potential variables and their interaction in patients with hypercholestolemia are discussed 
in subsequent sections; this is essentially, in fact, the nature of this research. However, a 
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review ofthe basic terminology, course of disease, and clinical interventions will provide 
the reader with a more comprehensive understanding of the factors under study. 
Hypercholesterolemia 
Hypercholesterolemia, simply known as high cholesterol, aflects 18% of 
Americans aged 18 to 74; this disease slowly clogs the circulatory system over a lifetime 
and directly leads to coronary heal1 disease, the single leading cause of death in the 
developed world (Harvard Health Publications, 2005; McGinnis & Foege, 1993). 
Vigorous physieal activity and a sensible diet can control and even reverse high 
cholesterol without the use of medieal intervention (Shelby, 2005). However, for some 
13 million Americans, on cholesterol-lowering medicines, diet and exercise do not appear 
to be a reliable treatment option. Thankfully, science has produced very powerful drugs 
that can counteract the long-term effects of hypercholesterolemia; therefore, high 
cholesterol and CVD become very treatable and preventable medical conditions. 
Moreover, the negative effects of arteriosclerosis, a condition directly related to and 
caused by high cholesterol, is also reversible (Harvard Health Publication, 2005). 
Cholesterol is a fatty, waxy, and naturally occurring substance belonging to a class of 
chemicals known as lipids and is an essential energy provider which fuels cells, serves as 
a primary building block of cell membranes, is used to make bile acids assisting in the 
digestion of food, and also is a very important precursor to vitamin D and hormones, 
including estrogen and testosterone (Harvard Health Publications, 2005). Obviously, 
cholesterol is very important to the body. Although the liver produces it naturally, alld 
cholesterol is naturally absorbed through the intestinal tract, the human body generally 
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produces more than an abundant supply. A problem, however, begins to develop when 
non-endogenous, or dietary cholesterol, becomes overabundant and upsets the ratio of 
lipids throughout the body. That is, cholesterol is classified into several different types, 
all with various and distinct influences on the body, Serum cholesterol, or blood 
cholesterol, is the total, regulated level of cholesterol available in the blood; a desirable 
level of total cholesterol is less than 200mg (Harvard Health Publications, 2005), 
Excessive serum cholesterol, and other metabolic debris that is left over after the body 
has consumed a sufficient amount of essential nutrients, travels through the vast network 
of arterial vessels throughout all regions of the body, The circulatory system is the 
distribution system for the transportation of lipids throughout the body. Although the 
bloodstream is an efficient delivery system for many types of nutrients, for compounds, 
and of course for oxygen; before some compOlmds can be transp0l1ed via the 
bloodstream they must be packaged and prepared for circulation. Because cholesterol is 
a lipid, or fat, dumping it directly in the bloodstream would cause it to congeal and form 
unusable and dangerous clots. Therefore, in order for cholesterol to be transp0l1ed 
effectively, it must be molecularly wrapped in proteins. The lipids, now wrapped in 
proteins, form tiny particles called lipoproteins. Although the bloodstream carries many 
types of lipoproteins, when it concerns heart disease the most imp0l1ant lipoproteins 
include high-density lipoproteins (HDL), low-density lipoproteins (LDL), and very-Iow-
density lipoproteins (VLDL) (Harvard Heath Publications, 2005). Each ofthese 
lipoprotein substanees has very different effeets on the body. For example, LDLs may 
come from two sources, genetic heritage and dietary habits, but regardless of their 
origins, excessive LDLs become problematic and dangerous to the circulatory system. 
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That is, after a substantial amount of time, excessive pressme in the bloodstream, or 
exposme to toxic agents such as nicotine, homocysteine, or excessive blood sugar, the 
circulatory system may sustain "nicks" or small abrasions on the inner smooth lining of 
vessel walls. In a natural process, the body attempts to repair these "nicks" with LDL's ; 
in turn, excessive repairs of "nicks" trigger more LDLs needed to repair, thereby causing 
an overabundance of "repair" lipids over a "nick", ultimately creating a plaque build-up, 
obstructing blood flow leading to cardiovascular and cerebrovascular disease. 
Conversely, as LDL's contribute to arteriosclerosis, HDLs provide a collection function, 
"picking-up" other fatty substances, such as LDL's and VLDL's and move them through 
the bloodstream to the liver and intestine, places where lipids are disposed. 
Understanding the process of aIieriosclerosis and eventual CVD is by no means simple or 
uncomplicated. However, George, Kong, Thoman, and Stewart (2005) concluded that 
knowledge of the disease process, among other factors, is optimal for treatment 
adherence in patients with chronic obstructive pulmonary disease (COPD). Therefore 
patient education becomes an important primary prevention factor in helping promote 
medication adherence and overall healthy patient outcomes. Yet, the apparent 
physiological dichotomy of average American citizens' trend toward increasing rates 
obesity and CVD is the leading cause of death in Americans. 
Statin Therapy 
As the pharmaceutical industry continues to advance the science, technology, and 
variety of treatments used to control high cholesterol, Americans are in fact enjoying 
longer life spans and improved quality of living. In particular, powerful cholesterol-
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lowering drugs called reductase inhibitors, or commonly called statins, are continuing to 
show promising evidence against the ill effects of high cholesterol (Harvard Health 
Publications,2005). Current research also reveals an arterial anti-inflammatory function, 
antioxidant effects, and an anti-carcinogenic function in animal models, in addition to an 
impressive cholesterol-lowering function of the statin class of medications (Davigon & 
Laaksonen, 1999). To date there are five well-known, brand-name statin medications on 
the market used to remediate hypercholesterolemia (Harvard Health Publications, 2005). 
Zocor, Crestor, Lipitor, Vytorin, and Provachol vary in their chemical compounding, but 
essentially provide the same effects on the hml1an body. The statin drugs work, in pal1, 
by increasing the absorption rate of low-density lipoproteins (LDL's) by the liver as it 
filters blood, and these generally are well tolerated in lal'ge clinical trials (Tomlinson, 
Chan, & Lall, 2001). Although some fortunate people have been endowed with naturally 
low levels ofLDL's, and sufficiently high levels ofHDL's, others have to maintain a 
vigil over the types of foods consumed and the amounts of exercise practiced throughout 
the week. When considering how one becomes diagnosed with hypercholesterolemia, 
two critical factors are important to consider. Genetics and healthy behavior are two of 
the most influential val'iables associated with the development of high cholesterol 
(Harvard Health Publications, 2005). Although the treatment for inheritable high 
cholesterol is primarily medication, with adjunctive exercise and proper diet, patients 
with non-inheritable high cholesterol are initially and strongly encouraged to initiate 
treatment with dietary and lifestyle modifications. Shelby (2005) reports that aggressive 
dietary changes can lower the lipid profile more than 30% by consuming a diet high in 
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sterols, high in soluble fiber, and coupled with the consumption of less than 200 
milligrams of cholesterol daily. 
To date, there is little in the literature with regard to the psychological effects of 
the cholesterol lowering drugs called statins. Although not all cardiac related drugs 
wan-ant such study, the statin class medications are an interesting group because they are, 
in part, prescribed as preventative and prophylactic against coronary artery disease 
(CAD) and cerebral infarct (stroke) (Davigon and Laaksonen, 1999). Additionally, statin 
medications are well known to the public, with an estimated 50 million patients on statin 
therapy; this class of dmgs is one of the most frequently prescribed in America today 
(Harvard Health Publications, 2005). As a point of interest, although statin medications 
have become very popular, the rates of obesity in middle aged adults, young adults, and 
children have also significantly increased over the past several years (CDC, 2004). 
Further, despite well published guidelines by the American Heali Association regarding 
healthy eating, the average American consumes, in a conservative estimate, 256 
milligrams of cholesterol a day, which is 20% over the amount suggested for a healthy 
lifestyle (Shelby, 2005). Given the over-consumption of cholesterol laden food items, the 
lack of diet adherence in general, and the propensity for a sedentary lifestyle, it would 
appear logical that Americans are exposing themselves to early mOliality. An argument 
can easily be made that, as a possible result of medical and pharmaceuticals teclmology, 
Americans may be paying less and less attention to their diet and exercise habits and 
becoming more and more reliant on the use of statin medication to control the effects of 
poor dining choices and sedentary lifestyles. However, it may be unfair to critize all as 
simply making bad choices; as mentioned previously, not all cholesterol comes entirely 
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from food sources. In fact, the human body would create more than enough cholesterol, 
even if none were obtained from diet (Harvard Health Publications, 2005). 
Davigon and Laaksonen (1999) have provided additional evidence to suggest that, 
in addition to their low-density-lipoprotein lowering effects, statin medication have other 
beneficial effects including anti-inflammatory properties, antioxidant effects, 
anticarcinogenic effects in animals, anticoagulant effects, stabilization of atherosclerotic 
plaques, and inhibition of graft rejection after heali and kidney transplantation. With 
fmiher promising research to come, even suggesting even that statins remove plaque 
build-up on alierial walls thereby reversing CVD, and providing a minimal blood 
thinning action, it would appear that several patients and physicians will gain even 
greater confidence and have much to celebrate regarding this remarkable class of drugs; 
this may lead to higher levels of over-confident eating. 
Diet, Exercise, and Health Beliefs 
With seemingly effortless access to fast food, generally poor eating habits, and an 
increasing sedentary lifestyle, the American popUlation is ripe for a variety of primary 
health concems, including hypercholesterolemia, diabetes, and hypeliension. The 
amount, and the availability of fast food is certainly not the primary reason so many 
Americans have, or will develop, hypercholesterolmia, hypeliension, or diabetes; 
however, the American diet in general, the attitude toward exercise and physical activity, 
portion regulation, eating habits, health care beliefs, stress management skills, and beliefs 
around the effectiveness and protectiveness of cardiac and anti-hypertensive medicines 
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must be investigated further to determine what influence, if any, these variables have on 
positive health behaviors and healthy outcomes. 
The National Institute of Health Technology Assessment Conference reports that 
one-quaI1er of Americans me overweight; as many as 40% of women and 24% percent of 
men are trying to lose weight at any given time; moreover, many have tried diet, exercise, 
behavior modification, as well as the use of drugs to achieve their goals. Yet, the NIH 
also reports that, in controlled settings, participants who remained in weight loss 
programs generally lost 10% of their weight; however, a disappointing one-third to two-
thirds of their weight was regained within one yem and nearly all the weight was 
regained within five years. CUlTently, obesity has become an epidemic problem in 
American culture, with the ill-effects being suffered across all racial divisions, and age 
groups-especially children. For example, Popkin and Udry (1998) reported a sample of 
third generation American children of various ethnic backgrounds including Anglo, 
African-American, Hispanic, and Asian-American adolescents; in their sample of 13,783, 
the authors fotmd that 26.5% were obese, and of this sample the majority of obese 
children were black non-Hispanics, followed by Hispanics, white non-Hispanics, and last, 
Asian American adolescents. Furthermore, Popkin and Udry (1998) rep0l1 that in all 
ethnic groups obesity was more prevalent in males than in females and Asian-American 
and Hispanic adolescents born in the U.S. were more than twice as likely to be obese than 
were first generation residents. To illustrate further the obesity epidemic in the United 
States, Allison, Fontaine, Manson, Stevens, Vanltallie (1999) report the estimated 
number of annual deaths directly attributable to obesity in 1991 was 325,000. Kujala, 
Kaprio, Sarna, and Koskenvuo (1998), however, rep0l1 diet and exercise habits can, and 
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do, dramatically improve longevity and the quality oflife for many. Although not all 
individuals who are obese ultimately suffer cardiac events directly related to poor diets, 
the data regarding current rates of obesity and the mOliality rates due to obesity are 
discouraging, and appear to reflect a negative change in the American cultural approach 
to diet and exercise. However, it is impOliant to mention that not all cases of 
hypercholesterolemia are related to the lack of exercise. For example, Halverstadt, 
Phraes, Ferrell, Wilund, Goldberg, and Hagberg (2003) report that HDL levels are an 
important risk factor for cardiovascular disease that may be modified through exercise 
training; however, the levels ofHDLs, and subfractions thereof, are highly variable 
among individuals, suggesting the response to exercise training may also be influenced 
by significant genetic variation and the interaction of genetic variation with physical 
activity. Although most, ifnot all health care providers will generally agree that routine 
exercise simply pays rich health dividends, not all obese or overweight individuals are 
solely interested in the health-related effects of exercise. The current struggle with weight 
loss, diet adherence, and exercise routines are common topics of conversation among 
many; however, not all individuals are losing and maintaining a healthy weight for the 
right reasons. Campos, Saguy, Ernsberger, Oliver, and Gaesser (2006) report the 
current diversity of cultural and ideological factors as driving the current, world-wide 
obsession with thinness, especially for young women and girls who have tendencies to 
demonize celiain foods, as well as the development of heavier bodies, in the spirit of 
fashion and cultural trends. 
Although there is overwhelming evidence to suggest that smoking habits, 
excessive alcohol consumption, diet, and rates of physical activity are impOliant 
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determinants of CHD, the complex interactions between diet, lifestyle and lipoprotein 
metabolism collectively detennine the eventual development of arteriosclerosis and 
related cardiac complications (Kromhout, Menotti, Kesteloot, and Sans, 2002). Yet other 
authors have argued that weight control should not be the primary targets when helping 
patients avoid CHD. For instance, Campos, Saguy, Ernsberger, Oliver, and Gaesser 
(2006), contend that too many obesity researchers, diet researchers, and clinicians believe 
that the only point of a healthy lifestyle is simply to make people thin, or to keep them 
from getting fat Conversely, the need to maintain healthy and protective lipid proflles is 
generally the first strategy in helping patients achieve healthy outcomes. To this end, a 
balanced, but varied diet, rich in fiber, fruits, vegetables, and antioxidants, as well as 
heart protective omega-3 oils should be the focus of lifestyle and belief changes. 
Although any reader can find these healthy suggestions, and much more, in a wide 
variety of general periodicals, in health related magazines, and in physician education 
brochures, the American public, as well as American physicians, are continually 
bombarded with trendy advertisements stressing the importance of discussing the 
potential benefits of new medications. 
At a cursory review, it appears that Americans greatly value the efficacious 
results that powerful medications have on a myriad of medical conditions which, if not 
treated, can lead to life-threatening physiological disease and profound psychological 
distress. By simply picking up any common periodical and perusing the contents, the 
health care priorities of the American public become very clear. That is, the American 
culture appears to be a medicine-seeking popUlation. For instance, the American 
Academy of Physicians Assistants report that in 2005, physician assistants alone wrote 
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278,000,000 prescriptions. This statistic indicates an increase of more that 26 million 
prescriptions from 2004. Interestingly, Calandra (2001) repOlis that over the past decade, 
health club memberships have increased by only one-third to approximately 30 million 
total members throughout the United States. These trends in prescription-seeking and in 
exercise habits suggest a greater need for expedient medical treatment and less concem 
for lifestyle modification. The sheer number of medication advertisements and the 
attractive manner in which they are adveliised can provide any casual reader or television 
viewer with a reasonable amount of evidence for the value Americans place on 
medications. In fact, most pharmaceutical adveliisements provide a simplified symptom 
checklist, on which potential patients, or more accurately, consumers are asked to 
endorse the presence, or absence, of certain symptoms. This advertising process may 
minimize, or negate the need for patients to manage their diabetes, hype11ension, or 
hypercholesterolemia with lifestyle modification, namely diet and exercise, while 
concomitantly undermining the physician's role as educator. With a patient-driven 
healthcare market, it is apparent that the phmmaceutical industry maintains successful 
marketing programs, which are directly targeting patient populations. Additionally, 
patients are provided with enough information about the helpful effects of prescription 
dmgs while simultaneously emphasizing the current debilitating effects of their unique 
disease states, that a state of anxiety occurs and energizes their prescription seeking 
behavior and their beliefs that medication is the most time sensitive and efficacious 
treatment option. Yet the literature regarding the efficacy of diet and exercise habits in 
treating primary health conditions and the ill effects of a sedentary lifestyle is very well 
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established (Shelby, 2005; McGuinnis & Foege, 1993; Kujala, Kaprio, Sarna, & 
Koskenvuo, 1998). 
The current study is important because health-related beliefs and health-related 
behaviors are becoming increasingly important factors when considering the potential 
mediating or moderating variables that may drive patients' chief complaints, treatment 
adherence, or medication reliance. For example, a review of the literature on diabetes 
management suggests levels of noncompliance with treatment is related to an individual's 
personal health belief model, and to prejudgment by health care professionals about what 
patients can accomplish, based on their age, education, or socioeconomic status; this may 
lead to negative outcomes (Leichter, 2005). Additionally, noncompliance with 
medication regimes among patients with bipolar disorder reveals rates of noncompliance 
as high as 64%; knowledge of the factors associated with noncompliance would enhance 
clinical management and help patients achieve positive outcomes (Colom, Vieta, 
Maliinez-Aran, Reinares, BenabalTe, & Gasto, 2000). As such, a reasonable argument 
can be made for patients who medicate on cholesterol lowering drugs. Specifically, it is 
desirable to study the psychological effects that statin medications have on patients' 
belief systems. Initially, some fundamental questions al'e raised. For example, does 
taking statin medicine enhance a patient's overconfident eating behavior after he or she 
begins the regime alld is able observe how quickly positive effects are obtained? 
Similarly, does taking the medicine foster an overconfident belief in the medicine's 
protective value, thereby reducing the perceived need to paliicipate in routine exercise 
programs and to reduce sedentary lifestyle? The answer to these questions will yield 
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imp0l1ant conclusions, impacting the patient's quality of life, his or her belief system, as 
well as a physician's prescribing behavior and role as educator. 
Health Belief Model and Social Learning Theory 
As a mediating or moderating variable that potentially influences a person's 
belief system, the Health Belief Model (HBM) can have long reaching influences on 
health and behavior. An entire discipline of clinical psychology has been dedicated to the 
investigation, understanding, and remediation of illogical, even unhealthy beliefs. The 
study of Social Learning and Cognitive Therapy, with pm1icular influence from the 
HBM, can provide the necessary cognitive framework when considering potential 
mediating or moderating variables, which may ultimately influence a person's health 
related outcomes. Although the strength and salience of an individual's belief system 
originate from a variety of sources, cognitive therapists suggest that core beliefs, or 
schema, are developed over the course of an individual's lifetime and are influenced by 
environmental, cultural, and personal variables including fmnity and social history, 
reinforcement histories, education, temperament, intelligence, socio-economic status, and 
even religious practices (Freeman, Pretzer, Fleming, & Simon, 1990). In attempting to 
understand how cognitive and behavioral variables influence beliefs associated with 
health maintenance and disease prevention, a review of the major conceptual models will 
provide a more specific foundation of knowledge in understanding what motivates some 
persons to adhere to medical regimes, participate in healthy diets, practice regular 
exercise, regulate overconfidence, and maintain overall healthy outcomes. 
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The HBM is a conceptual system for helping to understand, explain, and predict 
preventative health behaviors (Janz & Becker, 1984). The HBM otTers five descriptive 
areas which are believed to influence health beliefs and behavior: 1) the individual's 
perceived susceptibility to illness, 2) the perceived seriousness of the disease, 3) the 
perceived benefits of taking action, 4) barriers interfering with action, 5) cues to taking 
action, and self-efficacy; these are the major tenets that frame the HBM (Wiebe and 
Christensen, 1997). Investigating individuals' beliefs according to these major domains 
will yield patients' conceptualization of their conditions, as well as their resources to 
cope with, and take action against the diseases or predict how patients maintain healthy 
beliefs and behaviors. The HBM has been applied to a variety of chronic medical 
conditions. For example, Patino, Sanchez, Eidson and Delmater (2005), have applied the 
HBM to a sample of minority adolescents with type I diabetes and concluded that 
evidence was provided to suggest that youth with type I diabetes mellitus reported greater 
short-term health risks, compared to longer-term risks, but perceived less risk to 
themselves as compared to others. Although the study did not provide support for the 
HBM's predicting regimen adherence, the application of the HBM is nevertheless helpful 
in gaining a preliminary understanding about the reasons why some patients hold 
pa11icular belief systems that may be counterproductive to healthy outcomes. Similarly, 
George, Kong, Thoman, and Stewat1 (2005) concluded that health beliefs, knowledge 
about and faith in the treatment, routinization of drug therapy, knowledge and acceptance 
of the disease process and recommended course of treatment are critical variables for 
optimal adherence in patients with chronic obstlUctive pulmonary disease (COPD). 
Although many attempts have been made to understand the theoretical reasons for non-
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adherence, the mainstay of several studies has been isolated to specific clinical 
populations and has examined specific factors including patient intelligence, familial 
support, socioeconomic status, patient education, dosing effects, and physician/patient 
interaction, to cite only a few. Although the influence of these variables cannot be 
overstated, George, Kong, Thoman, and Stewart (2005) also report patient education 
directed at focusing on the course of the disease, as well as education regarding the need 
for long-term treatment may help improve patient adherence; yet the authors also report 
patients may be likely to alter the recommended course of management, based on how 
they feel and believe, especially if the disease is relatively symptomatic as is the case for 
COPD. 
Similar in some respects to the HBM, Social learning theory suggests that the 
social environment is a significant source of behavior cues providing the impetus for 
influence over human behavior. Baranowski, Perry, and Parcel (1997) suggest that a 
systematic review of the relevant enviromnental constructs associated with non-
adherence, places health care providers in an advantageous position to facilitate positive 
patient outcomes and discourage unhealthy outcomes. For example, individual 
components of Social Learning Theory; including environment, expectation, self-control, 
and reinforcement, among other components, suggest that patients will not actively 
engage in healthy outcomes if they do not expect the outcome to be successful; therefore, 
engendering a sense of self-efficacy becomes a primary factor in facilitating positive 
patient outcomes (Glanz, Lewis, & Rimer, 1990). 
Another model for predicting healthy patient outcomes involves a review of Self-
Regulation Theory. Leventhal, (1984) suggests that a patient's adherence to any 
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treatment regime is intimately connected with the manifestation of physical symptoms 
and illness memories, thereby mediating the compliance process. For instance, a clear 
example of Self-Regulation Theory can be found in a review of kidney transplant patients 
studied by Siegal and Greenstein (1998). In their study, the authors repOlied patients 
were most likely to adhere to their treatment regimes when they were convinced that their 
medications must never be missed, their medications' effects are no longer effective after 
a day, and physical symptoms interfered with the activities they needed to complete. 
Conversely, partial compliers were not likely to believe that the medication was essential, 
that the therapeutic half-life was greater, and that their physical symptoms were 
considered milder when compared with the previous group. 
Biopsychosocial Model 
In order to assess any health-related question properly, a belief in, and practice of 
the biopsychosocial model provides one of the most comprehensive traditions to 
conceptualize a patient's presenting problem(s). Stedman's medical dictionary defines 
the biopsychosocialmodel as a conceptual model, which assumes that the psychological 
and social factors must also be included along with the biological factors in 
understanding an individual's medical illness or disorder. In assessing and treating for 
healthy patient outcomes, the biopsychosocial model mandates that patients undergo 
assessment(s) that are multifaceted and interdisciplinary, covering various disciplines that 
review individual factors specific to each area of expertise. This level of integration 
allows for comprehensive review of all systems that may play roles in disease 
manifestation, maintenance, and recovery. Conversely, the traditional biomedical model 
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postulates a conceptualization that excludes psychological and social forces in patient 
assessment and diagnosis, whereas the biopsychosocial model is more comprehensive 
and punctuates the importance of individual psychological and social differences. In 
studying the psychological, social, and behavioral effects of hypercholesterolemia, diet 
and exercise adherence, and providing overconfident beliefs about cholesterol-lowering 
medicine's effects on healthy behavior, the value of endorsing the biopsychosocial model 
cannot be overstated. That is, because high cholesterol cannot be attributed solely to 
genetic factors, the psychological, behavioral, and social influences of practicing routine 
exercise, consistently maintaining a healthy diet, and also practicing effective strcss 
management, such as controlling anger, maintaining good sleep hygiene, and scheduling 
routine relaxation time, become increasingly important in understanding how patients 
develop high levels of cholesterol, maintain the integrity of their treatment regimes, or 
prn1icipate in rehabilitative and preventative health measures. Concomitantly, 
understanding the micro and macro-social forces impacting on a patient's level of 
functioning is also critical in the biopsychosocial review of each patient's individual 
medical and psychological history. For instance, as the American culture becomes 
increasingly time-sensitive, goal-focused, and achievement-oriented, understanding and 
incorporating of the social influences of behavior, such as emotional stress, pollution, 
over-crowding, normative social influence of dieting and exercise, infol111ational social 
influence of medications, private acceptance, conformity, personal sleep habits, and the 
human body's response to long term adaptation to stressors must be considered in the 
holistic assessment of each patient. 
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As a part of the greater ecological systems, and perhaps one of the most 
influential detenninants of human behavior, the socially mediated forces that impact upon 
a patient's healthy or unhealthy outcomes includes the ever present economic market in 
which they currently function. As pharmaceutical companies continue to implement the 
very effective direct-to-consumer adveliisements (DTCA), the medical marketplace 
continues to be shaped by the sheer power and wealth that the pharmaceutical industry 
brandishes over consumers, prescribers, and legislators, using their very sophisticated and 
indulgent marketing campaigns in a fashion, ultimately, most advantageous to their own 
endeavors. For instance, Donohue and Berndt, (2004) repOlied that spending on DTCA 
increased from $266 million in 1994 to $2.6 billion in 2002, making this form of 
phmmaceutical marketing the object of substantial controversy. Rosenthal, Brendt, 
Donahue, Epstein, and Frank (2003) have additionally repOlied in a study, that the effects 
of DTCA accOlUlted for 12% of the increase in prescription drug sales between 1999 and 
2000. Consequently, an argument can be made for the development of overconfident 
belief systems that are essentially developed out of, and maintained by the propagation of 
a seemingly endless banage of medication cOlmnercials and adveliisements, by treatment 
programs, and by favorable prognosis as proliferated by the DTCA campaigns. In fact, 
Mintzes Barer, Kravitz, Bassett, Lexchin, Kazanjian, Evans, Pan, and Marion (2003) 
concluded that more adveliising leads directly to more requests for adveliised medicines 
and more prescriptions in general; fUlihermore, the authors contend that if DCTA is 
brought into a conversation between patients and physicians, that conversation is quit 
likely to end with a prescription, often despite the physician ambivalence about treatment 
choice. 
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It is important to understand that most if not all pharmaceutical companies 
practice this strategy as a marketing and sales tool in attempts to gain the greater market 
share for their products. That is, the influence DCT A campaigns on patients, the social, 
professional pressure to physicians, and tangible reinforcers that physicians receive on an 
almost daily basis may actually serve to entice patients to ask for the most well-
advertised medication and for the physicians to actually prescribe the most sought after 
medications. Lacasse and Leo (2005), in the case of antidepressant medications and the 
controversial serotonin hypothesis, maintain that DTCA campaigns are seductive to 
physicians and patients because patients who present with a "chemical imbalance" and 
are convinced that they are suffering from a neurotransmitter deficiency are most likely 
to seek a prescription for an antidepressant and they may be skeptical of physicians who 
suggest other interventions such as cognitive-behavior therapy. Nevertheless, the social 
messages embedded in some DCTA campaigns speak directly to patient consumers by 
suggesting the disease is predominantly caused by genetic inheritance with little 
influence from environmental or behavioral factors. Upon careful review of these 
campaigns, one can hear the bias toward the genetic inheritance of disease, thus 
assuaging the guilt of patients for not practicing exercise habits of healthy eating. Either 
directly or indirectly, the large and wealthy phannaceutical industry is shaping the 
relevant health beliefs and behaviors of many American patients and possibly of 
physicians. A review of other industrialized countries may provide interesting social 
correlations, especially when considering countries with advanced economies such as 
Asia and countries of the European Union. 
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Possessing an understanding of the biopsychosocial factors that influence high 
cholesterol can fmiher help physicians to educate and treat their patients in a number of 
ways. The information and data revealed in the Cl1nent study can assist physicians in 
understanding the nature of a patient's treatment adherence according to the influential 
and ever present biopsychosocial factors. Moreover, conceptualizing the whole patient 
from this perspective will provide suggestions of possible treatment barriers or of 
facilitators acting upon the patient, suggesting data for, or against, the likelihood that 
patients will, or will not, become over-confident regarding the effects of their 
medications, violate their dietary plans, or fail to practice cardiovascular exercise 
routinely. Similarly, patients can also benefit from lmderstanding their own 
biopsychosocial conceptualizations by improving their self-awareness regarding the 
behavioral and social factors that influence healthy or unhealthy behaviors. For instance, 
patients on cholesterol-lowering medicines can discover particular behavioral habits that 
may be unhealthy but are very consistent v'lith their cunent social or work environments. 
They can also discover a particular cognitive susceptibility to health related beliefs, such 
as over-confident eating, or the influence of social learning on health maintenance habits. 
An example may include the DTCA campaigns providing the socialleaming 
oppOliunities to create a minimization or rationalization effect, thereby undennining the 
importance of diet and exercise adherence. To illustrate fmiher the impOliance ofthe 
various biopsychosocial factors, Peyrot, McMurry, and KlUger (1999) found an 
interaction between biologic and psychological factors, with psychosocial factors 
accounting for more variance in glycemic control within Type 1 Diabetic patients; the 
authors found that stable psychosocial resources (i.e., education, being married, and 
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positive coping styles) were associated with better chronic glycemic control, but chronic 
stress and regimen nonadherence were associated with worse transient glycemic control. 
Similarly, a conceptualization from the biopsychosocial model provided evidence that 
elderly individuals are at an increased risk for CVD, especially if they are un-paI1nered, 
socially isolated, depressed, and report a poorer quality of life (Stuart-Shor, Buselli, 
Canoll, & Fonnan, 2003). 
Overconfidence 
An argument can be made that widespread technology, regardless of the field, 
may make consumers feel secure, comfortable, brave, lazy, entitled, or even 
overconfident. As the pharmaceutical industry continues to research and develop new 
drugs designed to promote wellness, cure diseases, and reverse debilitating conditions, 
some investigation seems necessary regarding the cognitive effects of such medical 
advancements. That is, do medicines mediate or moderate psychological belief systems 
related to health and wellness, prevention and cure, or even diet and exercise habits? In 
particular, the present study is designed to investigate the psychological effects that 
cholesterol-lowering drugs have on healthy patient outcomes. The need to study the 
psychological, specifically cognitive and behavioral effects of this class of medications is 
punctuated by their ever-growing popularity. As a construct, overconfidence suggests 
that an individual seems to believe that their reasoning processes, belief systems, and 
subsequent conclusions are just fine the way they are, and there is no need to take 
remedial action in the way they think or act (Aronson, Wilson, & Akert, 2005). 
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AdherencelNon-adherence and Locus of Control 
There are indications that health beliefs are significant predictors of adherence; 
specifically, the perceived threat of an illness as a health related belief has received 
widespread attention in the literature regarding treatment compliance and adherence 
(Carpenter, 2005). In the previous section, the role of overconfidence was reviewed, and 
was hypothesized as having an impact on the influence that statin medications have on 
healthy patient outcomes. Whether a patient adheres or does not adhere to his or her 
treatment regimen appears to be in some fashion related to overconfidence, and as 
Carpenter (2005) describes, it is also significantly related to the construct of perceived 
threat. That is, the motivation for any individual patient to non-adhere to a treatment 
protocol will be complex and interconnected with biological factors including the 
treatment's physiological effects, social factors including the ease, costs, and availability 
of prescribed treatments, and psychological variables including an individual's beliefs, 
about illness; these factors, however, may be central in the prediction of adherence to 
diet, exercise, and medication regimens. In particular, then, the current study suggests 
that there is a level of overconfidence which may develop because patients on statin 
therapy may be more likely to develop beliefs which are consistent with the notion that 
they are completely, or mostly, protected from future cerebrovascular or cardiac events. 
To fmiher substantiate this claim, the psychological construct of perceived threat could 
also be likened to a patient's locus of controL Locus of control refers to a learning 
process during which individuals develop a belief system whereby they believe, or 
predict, that certain outcomes are a result of their action (internals) or a result of other 
forces independent ofthemselves (externals) (Rotter, 1954). Essentially, understanding 
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patients' locus of control is helpful regarding their levels of perceived control of their 
illness and environmental demands. Similarly, the construct of Health Locus of Control 
was also derived from Social Learning Theory and developed out of Rotter's original 
work in 1954. However, Wallston, and Wallston (1978) recognized that there was 
difficulty in predicting health behavior specifically from generalized expectancy 
measures such as Rotter's scale. Moreover, Wallston and Walston (1978) also 
discovered through observations of recently diagnosed diabetic patients and their families 
that medical staff continued to stress the importance of the patient's active role in his or 
her own health care. It was clear, based on their efforts that the medical staff was trying 
to establish an internal locus of control in this patient population in anticipation of 
facilitating treatment adherence and positive outcomes. Through this observation, 
Wallston and Wallston (1978) developed the Health Locus of Control Scale (HLC), a 
scale similar to Rotter's original InternaVExternal Locus of Control Scale, but with 
specific application and item content unique to health care situations. The HLC scale is 
recommended in conjunction with behavioral measures to evaluate health education 
programs. Because it appears that individuals with higher levels of internal locus of 
control appear more likely to engage in positive health related behaviors and fewer non-
adherent behaviors, it is evident that the Health Locus of Control accentuates the 
significance of physicians as an educators, endorsing also the need to involve themselves 
in training patients to hold more intemal beliefs (Wallston & Wallston 1981). Thus 
patients would apparently be more likely to adhere to medical treatments, to low fat diets, 
and to exercise regimens if they perceived their behavior did in fact demonstrate causal 
relationships with positive and healthy outcomes; also included would be the physicians' 
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reinforcement of this belief. However, for some patients, the possibility of experiencing 
positive reinforcement, in this case healthy outcomes, as a result of their own healthy 
habits including exercise, dieting, or medication adherence may be too temporally and 
spatially discontiguous to affect their healthy behavior practices positively. For instance, 
Weiner (1986) suggests that Attribution Theory also provides a basis for understanding 
the human desire to assign attribution or causality to particular events in their lives when 
they are spatially and temporally contiguous. Additionally, Byrns (2000) studied thc low 
back pain of factory workers and concluded that employees who attributed pain to 
internal constructs including knowledge of back safety, for instance, had a tendency to 
experience less distress as compared with those who assigned external attributions. Last, 
the Protection Motivation Theory proposed by Rogers suggests that the value of fear 
coupled with communication and self-efficacy may lead to the motivation necessary for 
developing coping mechanisms such as positive, health-related behaviors. Ultimately, 
determining what facilitates or inhibits patients from adhering to prescribed courses of 
treatment is as individual and lmique as the patients themselves. The theories described 
above, provide a preliminary review ofthe potential mechanisms which may energize 
non-adherence. 
Rationale 
After direct observation and interaction with several individuals receiving statin 
therapy for hypercholesterolemia, a common pattern of behavior and a common theme of 
beliefs became ever present. That is, pursuant to these observations and interactions, 
individuals who were currently receiving statin therapy were feeling apparently more 
confident, less guilty, generally less concerned about indulging in overeating, making 
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poor diet choices, skipping exercise sessions; they also verbalized the belief that statin 
medications protected them from all the consequences associated with overeating, poor 
dieting, and lack of, or diminished, exercise routine. Although this observation was 
indeed casual and involved only a few individuals, these observations and interactions 
did energize curiosity and the desire to study this phenomenon under more controlled and 
efficacious conditions. To illustrate this point further, during the course of interaction, 
the majority of these individuals, both males and some females, rcported less concem 
about eating a high fat lunch or dinner because they were now on a "cholesterol 
medicine," and some even reported they could "not worry as much" as they had, prior to 
taking the medicine, because the medicine controlled their high cholesterol so effectively 
and efficiently that they felt comfortable indulging. Fmiher discussion revealed that 
individual exercise habits and general non-adherence to diet were perceived to be equally 
less impOliant, and were frequently and routinely violated. For instance, some repOlied 
beliefs of failure because exercise and diet regime did not significantly lower cholesterol, 
indicating that some individuals were genetically predisposed to have elevated 
cholesterol; others held beliefs of frustration, indicating difficult exclusionary diets and a 
strenuous exercise program lowered cholesterol levels only incrementally, yet low doses 
of statin medication lowered cholesterol levels much more significantly and in a quicker 
amount oftime. Interestingly, the individuals who felt fmstrated by the notion that the 
statinl11edication worked so well and so easily versus the need to change their lifestyles, 
including diet and exercise habits, felt more confident, by individual repOli, to eat 
anything and in any amount they desired. 
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It was this level of casual discussion, observation, and questioning that provided 
the impetus for the current research. Several research questions began to arise and the 
aspiration to investigate overconfident beliefs and subsequent unhealthy eating behaviors 
became apparent. Although the select few idiosyncratic observations and interactions 
may undeniably represent a skewed sample of the statin-taking population, it neveI1heless 
provides a rationale to study the phenomenon in a systematic and objective manner. 
Purpose of Study 
The purpose of the CUlTent study is to examine the psychological and behavioral 
concomitants that statin medications have on patients' eating habits, levels of 
overconfidence regarding diet non-adherence and exercise non-adherence, and their 
overconfident beliefs in the protective value of statin medications. Essentially, the 
central purpose of the present study is to identify relationships, if any, between the 
behavioral action of routinely taking cholesterol-lowering medication and the health 
related beliefs and behaviors which may be negatively altered to produce poor health 
outcomes pursuant to ingesting medication on a routine basis. The exact purpose of the 
study is not to review the powerful influence of placebos, nor to question the 
effectiveness of the statin family of medicines; however, the psychological influences, 
both behavioral and cognitive correlates, of consuming a statin drug on a regular regime 
is a worthwhile research endeavor by itself. 
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Research Questions and Hypotheses 
The research questions for this study were based on presumptions that patients 
who medicate on cholesterol-lowering agents, specifically statin medications, are 
susceptible to beliefs that motivate overconfident eating behaviors, diet and exercise non-
adherence, as well as substantiating overconfident beliefs in the protective value of statin 
therapy. In general, the hypotheses of this study purport that individuals who manage 
their hypercholesterolemia tlu'ough statin therapy will be likely to develop beliefs and 
behaviors that are consistent with unhealthy levels of overconfident eating, of diet and 
exercise non-adherence, and of overconfident beliefs in the medications' protective value. 
Specifically then, five hypotheses were separated and developed. They are as follows: 
Question 1: Is it accurate to suggest that among patients receiving statin therapy, the 
medication will successfully reduce levels of cholesterol from pre-medication levels, yet 
others anlong these patients will not respond positively to statin therapy? 
Hypothesis 1: Not all individuals taking statin therapy for hypercholoestermia will 
effectively lower and manage their high cholesterol due to other factors which mediate or 
moderate counterproductive unhealthy outcomes. 
Question 2: Will those patients whose cholesterol is significantly reduced by the effects 
of medication, endorse a level of agreement on statements that suggest diminished levels 
of exercise from pre- to post-medication time periods? 
Hypothesis 2: Patients who have reportedly improved their levels of cholesterol will be 
likely to engage in less freqllent exercise. 
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Question 3: Will those patients whose cholesterol is significantly reduced by the effects 
of medication endorse a level of agreement on statements that suggest diminished levels 
of diet adherence from pre- to post-medication time periods? 
Hypothesis 3: Patients who have rep0l1edly improved their levels of cholesterol will be 
likely to engage in less frequent diet adherence. 
Question 4: Will those patients, whose cholesterol is significantly reduced by the effects 
of medication, possess over-confident beliefs about the protectiveness oftheir statin 
medication? 
Hypothesis 4: Patients on statin therapy with improved levels of cholesterol will possess 
levels of overconfident belief regarding the medications protectiveness. 
~==~ Will beliefs about the causes of high cholesterol be related to diet and 
exercise non-adherence and medication overconfidence? 
Hypothesis 5: Beliefs and knowledge about the causes of high cholesterol are related to 
exercise non-adherence, diet non-adherence, and medication overconfidence. 
Participants 
CHAPTER 2 
METHODOLOGY 
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The paIiicipants for this study were randomly selected from a population of 
primary care patients receiving care from their primary care physicians' offices in eight 
locations. The primaI'y care practices were located in Northeastern and Southeastern 
Pennsylvania; one practice was located in New York. Either male or female participants 
of any racial background who were above 18 yeal'S of age, with a diagnosis of 
hypercholesterolemia (high cholesterol) were able to pal'ticipate in this study. The 
completed questionnaires of 64 participants with a diagnosis of hypercholesterolemia, 
who were receiving statin therapy, were included as analyzed data sets. PaIiicipants not 
diagnosed with hypercholesterolemia and/or younger than 18 years of age were excluded 
from the study. Partieipants were advised of their right to not participate in the study, as 
well as their right to withdraw from the study at any point in time. Participants were also 
required to read and comprehend the English language. 
Paliicipants were not required to sign an informed consent form, because no 
personally identifiable information was asked, recorded or otherwise collected. 
However, a letter of solicitation was attached as a cover letter identifying the 
investigators, their contact infOlTIlation, as well as the contact information ofPCOM's 
Institutional Review Board. There were no personal identifiers that could provide 
evidenee for tracking a paI'ticipant's endorsements on the collected surveys. Participants 
who were eligible for the inclusionaI), criteria were asked ifthey would be willing to 
participate in a research study designed to study the psychological effects of cholesterol 
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medication; they were asked to endorse their levels of agreement on a survey specific to 
the design and intention of the study. 
Design 
The current study uses various statistical methods including anovas, reliability 
coefficients, and descriptive statistics. Additionally, c011'elation measures are used to 
assess the degrees of relationships, if any, between numbers of different demographic 
factors and respondent's health related behaviors. The above mentioned statistical tests 
were engaged to determine the statistical properties between various factors, including 
health related beliefs specific to diet non-adherence, to medication overconfidence, and to 
exercise non"adherence. The demographic data described in the descriptive statistics 
consist of age, sex, medication dosage, length of time on medication, type of medication, 
frequency of exercise habits, and knowledge regarding disease and preventative care. 
Description of Instruments and Measures 
A 22 item demographic survey, and a 45 item survey of health-related beliefs and 
behaviors was constructed to solicit the levels of agreement that participants had on 
statements regarding several health-related beliefs and behaviors, including dietary 
habits, exercise habits, knowledge and beliefs about high cholesterol, locus of control, 
knowledge and beliefs about medication, knowledge and beliefs about the influence of 
exercise and diet on high cholesterol, basic demographic information, and a selection of 
statements determining the levels of beliefs and frequency of health-related behavior, 
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before and during statin therapy. The statements have been developed by the author and 
designed to provide an indication of agreement along a five-point Likert scale. 
Procedures 
Creation of Packets 
The measures were developed, assembled into identical packets (Appendix A), 
and were introduced with a brief solicitation letter (Appendix B) indicating the names of 
the researchers, a brief narrative describing the nature of the study, how to contact the 
researchers in the event that any questions arose, the right to discontinue at any point, 
detailed instructions about how to complete the surveys and an approximation of the 
length of time it would take to complete the surveys. The infOlmation contained in the 
cover letter was presented to the subject in language that was devoid of technical jargon. 
Each packet, including all forms within each packet, was numbered Icoded to ensure, that 
in the event a packet became disassembled, the researchers could match corresponding 
forms accordingly. Again, the study did not require the participant to provide any 
personally identifiable infOlmation on any forms or to any researcher directly. There 
were a total of 100 packets assembled; there was a response of 64 completed surveys. 
Survey Development 
The investigators developed the surveys for this study with careful and 
comprehensive consideration fi'om the relevant literature. Statements were designed to 
elicit a level of agreement along a five point Likert scale. In all, 42 statements were 
generated and each statement was fit into a specific subscale being studied. For example, 
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the purposes of this study were to reveal relationships between and among the 
consumption of stat in medication, overconfidence, and diet and exercise non-adherence; 
therefore, statements were constructed to solicit feedback along each of these factors. 
Surveys were also checked for ease of understanding, relevance, and content validity by a 
panel of fourth year graduate students in the context of a research methods class, by the 
Director of Research in Clinical Psychology at Philadelphia College of Osteopathic 
Medicine, and by the Chairperson of this research project. All comments and suggestions 
for change were carefully considered and the surveys were adjusted and revised when 
necessary. 
Site Selection 
Site selection was dete11nined by the willingness of the primary care physician to 
have his or her patients become available to volunteer in this study. The primary care 
practices previously listed were verbally solicited by investigators to determine their 
willingness to participate in the study. Physicians in private practices, group practices, or 
hospital-affiliated practices were advised to consult their individual institutional review 
boards, if necessary, and info11n investigators of any additional institutional review board 
requirements. Ultimately, none of the sites had additional institutional review board 
requirements. 
Participant Recruitment 
Once the study officially began, a researcher personally delivered the packets to 
the sites and provided info11nation and training on the distribution of packets to patients. 
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One primary care nurse or receptionist at each site was identified as the distributor and 
collector of the completed packets. The manner in which the packets were assembled 
and constructed allowed for an entirely self-explanatory completion of the packet and 
required little or no interaction from the distributor. To recruit participants, the 
distributor asked all patients who presented to the primary care practice over a 10-day 
period to participate in a research study investigating the psychological effects of 
cholesterol medication and health-related beliefs. The distributor also indicated to the 
patient the survey would take approximately 15-20 minutes to complete; that it would 
contain no items that would identify any personal information, and that the patient could 
discontinue the survey at any point without any consequence to his or her care. If the 
patient agreed to participate in the study, the distributor handed the patient a complete 
packet, asking him or her to read the directions carefully, fill out the survey completely, 
and hand it back into the distributor when completed. This process continued until 64 
different patients, henceforth referenced as participants, had completed the surveys. 
After 64 individual surveys were completed the data collection phase ofthe study was 
complete and no further direct interaction with participants occurred. 
Data EntlY, Statistical Analysis and Data Reporting 
Raw data compiled from completed surveys was coded, and for some items, was 
reverse scored, and initially entered into a Mircrosoft Excel spreadsheet for visual 
inspection and ease in the data management. Subsequently, the coded data were 
imported into the Statistical Program for the Social Sciences (SPSS, Version 14.0) for 
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psychometric analysis. Descriptive and inferential statistics were conducted, results 
analyzed, graphically displayed and reported. 
CHAPTER 3 
RESULTS 
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This study was eonducted over a one year period, from November, 2006 through 
November,2007. A total of 64 paliicipants completed the necessary questionnaires for 
this study. In order to fulfill the inclusion criteria, all participants were randomly selected 
from a population of primary care patients diagnosed with high cholesterol, who were 
cunent1y taking a statin medication to control high levels of cholesterol. Overall,61 
(95.3%) of the paIiicipants were diagnosed with high cholesterol and taking a statin 
medication. The remaining three participants either did not answer the questions 
assoeiated with diagnosis or were not taking statin medicine. Participation in this study 
was completely voluntary and each paliicipant completed a survey that did not reveal any 
personal identifying information. Additionally, data collected on the surveys eould not 
be tracked to individual paIiicipants. A signature verifying informed consent was not 
required because no personally identifying inforIllation was collected. However, ail 
introduction letter describing the nature, scope, and potential risks, was attached to each 
survey packet and included the researcher's contact infol1natiol1 (appendix A). 
Participants could freely remove themselves from this study at anytime with absolutely 
no negative influence to their care. All participants were over the age of 18. 
Responses to the Survey of Health-Related Beliefs and Behaviors 
The Survey of Health-Related Beliefs and Behaviors is a 45 item self-repOli 
survey which provides a series of statements whereby participants are asked to rate their 
levels of agreement on a five point Likeli scale, in which one (1) represents disagree; two 
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(2) represents somewhat disagree; three (3) represents neutral or unsure; four (4) 
represents somewhat agree and five (5) represents agree (Appendix C). The 45 items on 
the survey were broken down and classified into subscales. Specifically, subscales were 
developed to assess levels of agreement with each of the following constructs: 
medication-overconfidence protection, diet non-adherence after medication, diet non-
adherence before medication, exercise adherence before medication, and exercise 
adherence before medication (see tables 1-5). As a subscale, medication-overconfidence 
protection was developed to detelmine if a subject was likely to have an elevated sense of 
confidence in their medication's protectiveness against fiuther increasing levels of 
cholesterol produced by dietary habits (Cronbach's Alpha = .782). The subscale, diet 
non-adherence before medication involved a set of variables developed to detelmine the 
level of a subject's dietary habits before initiation of his or her current medication 
regime (Cronbach's Alpha .748). Diet non-adherence after medication included 
statements designed to solicit a subject's agreement on dietary attitudes and behaviors 
after medication was dispensed and taken (Cronbach's Alpha .435). Last, exercise non-
adherence before and after medication, both of which were single items, were developed 
to solicit agreement on a subject's level of cardiovascular exercise prior to struting 
medication and during his or her current comse of statin medication. The exercise 
subscales were developed as single items; therefore, reliability coefficients were not 
possible. 
In addition, pru1icipants were asked to complete a brief demographic survey 
(appendix B) consisting of20 items which requested participants to indicate their ages, 
races, length of time on cholesterol medication, recent changes in dosage, frequency of 
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exercise, cunent height, current weight, low-fat diet adherence, medication name, 
medication dosage, physician satisfaction with cholesterol levels, and questions related to 
health care knowledge. The following tables, graphs, and discussion represent the final 
results and provide descriptive statistics, correlations and anovas for the hypotheses of 
this study. 
Table 1 
Variables by Subscale 
Overconfidence 
1. Since I've been taking cholesterol-lowering medicine, I can eat anything I 
want. 
3. I believe my cholesterol-lowering medicine, without diet and exercise, 
completely protects me from developing higher cholesterol levels. 
5. Since I have been taking cholesterol-lowering medicine, I feel less worried 
about choosing what I eat. 
9. Taking cholesterol-lowering medicine regularly is more impOliant than 
maintaining a healthy diet. 
10. Taking cholesterol-lowering medicine regularly is more impOliant than exercise. 
11. Because I take cholesterol-lowering medicine I can eat "fast food" 2 or more 
times a week. 
15. I trust that the cholesterol-lowering medicine I am taking will effectively lower 
my cholesterol without diet and exercise. 
16. If my cholesterol level continues to remain high while on cholesterol-lowering 
medicine, I can have my dosage increased and continue eating any of the foods 
choose. 
21. Taking cholesterol-lowering medicine allows me to occasionally eat fattening 
food and over indulge. 
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Table 2 
Variables by Subscale 
Diet Non~Adherence after Medication 
8. Before I began taking cholesterol-lowering medicine, I ate "red" meat more than 
twice a week. 
18. Before I began taking cholesterol-lowering medicine, I ate more than 3 servings 
of dairy product daily. 
26. Before I began taking cholesterol-lowering medicine, I ate "fast food" 2 or more 
times a week. 
27. Before I began taking cholesterol-lowering medicine, I ate more than 5 servings 
of fruits and vegetables daily. 
29. Before I began taking cholesterol-lowering medicine, I was not worried about my 
diet. 
31. Before I began taking cholesterol-lowering medicine, I watched the portion size 
of my food servings. 
Table 3 
Variables by Subscale 
Diet Non-Adherence before Medication 
6. Since I have been taking the cholesterol-lowering medicine, I eat "red" meat 
more than twice a week. 
7. Since I have been taking cholesterol-lowering medicine, I eat more than three 
servings of dairy products daily. 
19. Currently, I eat five or more servings of fiuits and vegetables daily. 
28. Currently, I eat "red" meat more than twice a week. 
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Table 4 
Variables by Subscale 
Exercise Adherence before Medication 
30. Before I began taking cholesterol-lowering medicine, I practiced cardiovascular 
exercise 3 times a week (for at least 30 minutes) or more. 
Table 5 
Variables by Subscale 
Exercise Adherence after Medication 
12. Since I have been taking cholesterol-lowering medicine, I practice 
cardiovascular exercise 3 times a weck or more. 
Descriptive Statistics 
Of the 64 participants who voluntarily completed surveys for this study, 24 
participants were males (37.5%) and 40 were females (62.5%) (Figure 1). A total of 51 
(79.7%) p31iicipants were White, eight (12.5%) were Black, 3 (4.7%) were Hispanic, and 
two (3.1 %) were Asian. None of the p31iicipants described himself or herself as "other" 
(Figure 2). Regarding age, the largest group of participants, 19 in total (29.7%) 
indicated they were between the ages of 46-55. The second largest group, 14 (21.9%) 
participants, repOlied they were between the ages of 56-65. The third largest group of 
participants with regard to age consisted of the 13 (20.3%) participants who repOlied their 
ages as 36-45. The respective age ranges of the remaining participants consisted of 12 
(18.8%), who repOlied their ages as 66 or older, 3 (4.7%) 26-35, and 3 (4.7%), who 
repOlied their ages as 18-25 years old (Figure 3). A significant number of participants, 
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27 (42.2%), reported taking statin medication(s) for a period of 2-4 years, with the second 
largest group, 23 (35.9%), who indicated a period of one year or less on statin 
medication(s) (Figure 4). 
Sex 
Male Female 
Figure 1. Nmnber of participants by sex. 
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Figure 3. NlU11ber of participants by age ranges. 
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Figure 4 represents the length of time on medication; it shows the greater number 
of participants, 27 (42.2%), reported taking a statin medication for a period of two 
through four years, and the second largest group, 23 (35.9%) of the pmiicipants reported 
taking a statin medication for a time period of one year or less. The third largest group, 6 
(9.4%) ofpaliicipmlts repOlied having been on medicine for a time period of five through 
seven years, with the fewest number of participants, 2 (3.1 %) reportedly have taken statin 
medication for a period of 8 through ten years. Four participants (6.3%) did not select a 
time frmlle, and one respondent repOlied having taken statin medication for a period of 
twelve years. 
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Figure 4. Number of participants by length of time on medication. 
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Figure 5 displays the frequency of weekly exercise sessions indicated by 
participants, with the largest groups represented in the following categories, 18 (28.1 %) 
"I rarely practice cardiovascular exercise," and 18 (28.1 %) repOlted "less than three time 
weekly." Fifteen (23.4%) ofthe pmticipants reported, that they exercised "more than 
three times weekly," and 13 (20.3%) who responded as "3 times weekly." 
Frequency of Exercise 
20 
< 3x wkly 3xwkly > 3xwkly Rarely practice 
Weekly Exercise Sessions 
Figure 5. Number of paliicipants by number of weekly exercise sessions: greater than 
three times weekly; tIu'ee times weekly; less than three times weekly; rarely practice 
cardiovascular exercise. 
25 
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Body Mass Index 
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Classification 
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Obese 
Figure 6. Number of participants classified by Body Mass Index (BMI). 
According the Body Mass Index (BMI), 23 (35.9%) of participants were 
classified as overweight or obese. The remaining 17 (26.6%) were classified as being of 
n01111al weight. One respondent did not provide his or her height and weight, therefore 
BMI was not able to be calculated. 
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Dietary Habits 
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Figure 7. Number of participants by self-rating of integrity of dietary habits. Key: 
Honest Follow a low-fat diet daily and honestly; Cheat = follow a low-fat diet, but 
sometimes I cheat; D/U I do not usually follow a low-fat diet; D/K = I do not know 
what a low-fat diet is, 
As illustrated in figure 7, 42 (65.6%) of the participants indicated: "Sometimes I 
cheat," with 15 (23.4%) who reported they "don't usually follow," and 6 (9.4%) 
participants indicated they follow a low fat diet "daily and honestly." Only one 
participant did not know what a low-fat diet was. 
Most pmiicipants reported knowing the ill effects of untreated cholesterol. Sixty-
one (95.3%) reported untreated cholesterol is likely to lead to a heali attack and/or stroke. 
Regarding the pmiicipants' knowledge of the origins of cholesterol, Figure 8 represents 
the following: 44 (68.8%) repOlied cholesterol comes from "all of the above"; 8 (12.5%) 
repOlied cholesterol comes from "food"; 5 (7.8%) repOlied cholesterol is the product of 
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"genetics," and 1 (1.6%) reported high cholesterol results from "too little exercise." Six 
participants did not respond. 
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Figure 8. Knowledge about the origins of cholesteroL 
Regarding cholesterol levels, 43(73.4%) of participants indicated their cholesterol 
levels improved as a result of medication; 12(18.8%) reported their cholesterol levels 
stayed the same or worsened (Figure 9). Seventeen (26.6%) indicated their dosage was 
increased; 37 (57.8%) reported their dosage "stayed the same," and 5 (7.8%) indicated 
their dosage decreased (Figure 10). Figure 11 illustrates the number of pmiicipants by 
milligram of dosage. 
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Figure 9. Change in cholesterol levels. W/SS indicates cholesterol levels have worsened 
or stayed the same. 
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Figure 10. Change in medication dosage. 
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Figure 11. Number of participants by medication dosage. 
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Hypothesis # 1 
It was predicted that not all individuals receiving statin therapy for 
hypercholesterolemia will effectively lower and manage their high cholesterol due to 
other factor, which may involve behavioral correlates, including exercise non-adherence 
and diet non-adherence as well as cognitive correlates, including an overconfident belief 
in the medication's protectiveness. Although data indicate that 47 (73.4%) pmiicipants 
repOlied improvement in their cholesterol levels, 12 (18.8%) pmiicipants reported their 
cholesterol levels stayed the same or actually worsened during their course of stain 
therapy. Interestingly, 17 (26.6%) pmiicipants repOlied their physicians have increased 
their doses of medication, and 37 (57.8%) indicated their physicians have not changed the 
dosage of their medications. Last, only 5 (7.8%) participants indicated that their 
physicians have actually decreased their dosage of medication. 
Hypothesis # 2 
It was predicted that participants who have effectively improved their current 
levels of cholesterol would be likely to engage in less frequent exercise. A repeated-
measures ANOV A was conducted to assess whether or not there was a difference in 
pmiicipants' repOlied practice of cardiovascular exercise three times a week or more. 
Results indicated that, contrary to what was predicted, participants whose cholesterol 
improved engaged in significantly more exercise after medication treatment (]vI = 2.98, 
s.d. = .21) than before medication treatment (M= 2.59, s.d. = .20; F (1,45) = 5.56,p 
<.05, eta2 = .11). As suggested by Cohen (1988) an eta above .31 is considered a large 
effect size. This analysis revealed an eta of .33 (the square root of eta2 = .11) and is thus 
considered a large effect size. 
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Figure 12. Participants' levels of agreement with the following statements: "Since I 
have been taking cholesterol-lowering medicine, I practice cardiovascular exercise 
three time a week or more." "Before I began taking cholesterol-lowering medicine, I 
practiced cardiovascular exercise three times a week or more." Where DA=disagree, 
S/DS=somewhat disagree, N=neutrallunsure, S/A=somewhat agree, A=agree. 
Hypothesis # 3 
It was predicted that participants who have effectively improved their current 
levels of cholesterol would be likely to engage in less frequent diet adherence. A 
repeated-measures ANOVA was conducted to assess whether or not there was a 
difference in pmiicipants' reported practice of good dietary practices. Results indicated 
that, as predicted, participants whose cholesterol improved engaged in signiticantly less 
diet adherence after medication treatment (}.If 2 .. 7, s.d. = .14) than before medication 
treatment (M= 3.04, s.d. = .22; F (1,25) 12.84,p <.05, eta2 = .34). This analysis 
revealed an eta of .58 (the square root of eta2 .34) and is thus considered a large effect 
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SIze. This result should, however, be interpreted with caution because only 25 of the 47 
respondents whose cholesterol improved completed all of the diet adherence questions 
from before and after medication treatment. 
Hypothesis # 4 
It was predicted that participants on statin therapy who have improved levels of 
cholesterol will possess a level of overconfident beliefs regarding the medications 
protectiveness. Overconfidence was defined as a situation in which a subject responded 
to any ofthe overconfidence variables as "somewhat agree," or "agree" (see Table 1). 
The data reveal that 83% of the participants indicated they "somewhat disagree" or 
"disagree" with the statements assessing overconfidence. The remaining 17% indicated 
they were "neutral/unsure," or "somewhat agree." 
Hypothesis # 5 
It was predicted that beliefs about the causes of high cholesterol are related to diet 
and exercise non-adherence and overconfident medication protection. Smprisingly, 
individual beliefs are negatively related to exercise and diet non-adherence as well as to 
medication overconfidence. Specifically, the variables "1 believe my cholesterol is 
caused by poor diet" was negatively related to the variable "Since I have been talting 
cholesterol-lowering medicine, I practice cardiovascular exercise three time a week or 
more" (-.397**). Also, the variables "I believe my high cholesterol is caused by lack of 
exercise" was negative related to the variable "Since I have been taking cholesterol-
lowering medicine, I practice cardiovascular exercise three times a week or more" 
(-.422**). 
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Table 6 
Interconelations for Personal Beliefs and Exercise and Diet non-adherence before and 
after Statin medication therapy. 
V43 
V44 
V45 
Diet b-4 Diet-non V30 
Pearson Correlation -.285 -.281 .260 
Sig. (2-tailed) .120 .092 .078 
N 31 37 47 
Pearson Correlation .168 .220 -.267 
Sig. (2-tailed) .365 .191 .070 
N 31 37 47 
Pearson Conelation .171 .113 -.191 
Sig. (2-tailed) .358 .505 .198 
N .31 37 47 
V 43 I believe my high cholesterol is caused by genetics 
V 44 I believe my high cholesterol is caused by poor diet 
V12 
.147 
.331 
46 
-.397** 
.006 
.46 
-.422** 
.003 
46 
V 45 I believe my high cholesterol is caused by the lack of exercise 
Diet b-4 Diet non-adherence before medication (see table 3) 
Diet-non Diet non-adherence after medication (see table 2) 
V30 Before I began taking cholesterol lowering medicine, I practiced 
cardiovascular exercise 3 times a week or more 
V12 Since I began taking cholesterol lowering medicine, I practiced 
cardiovascular exercise 3 times a week or more 
Overcon Overconfidence variables (see table 1) 
** Correlations are significant at the 0.01 level (2-tailed). 
Overcon 
-.077 
.608 
47 
.013 
.931 
47 
.270 
.067 
47 
CHAPTER 4 
DISCUSSION 
Statin Effects 57 
With obesity, hypertension, and coronary herui disease indicated as leading 
conditions of American mOliality, a closer review of patient health-related behavior 
involving the prevention of chronic disease seems wananted. However, to date there has 
been scant literature available on the purely psychological effects that medical 
interventions themselves elicit in patients. Psychologically related variables including 
health and wellness beliefs, cognitive distOliions, overconfidence, logical fallacies, social 
confonnity, nomlative social influence, various behavioral principles and the related 
emotional correlates playa critical role in health maintenance and disease prevention; 
they also may actually playa role in the exacerbation or the pathogeneses of celiain 
diseases. Although medical and surgical interventions are indeed intended to improve the 
functional capabilities of patients who struggle with a myriad of diseases, one must begin 
to question if the actual interventions poses any psychological complications which 
contraindicate, or stand in complete contrast, with the actual procedure. 
For example, one intention of this study was to discover a relationship between 
diet and exercise non-adherence of pruiicipants who are currently prescribed statin 
medications to improve their cholesterol. Another intention of the study was to discover 
a relationship between patient overconfidence regarding medication protectiveness and 
respondents' eating and exercise behaviors. Although these hypotheses make strong 
conceptual sense, practically they were difficult to validate accurately. That is, capturing 
sincere, honest patient behavior appears practically impossible. Psychologists are very 
well aware of, ruld control for, a respondent's capacity to provide more favorable results 
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which are intended to cast a flattering review oftheir response pattern to the evaluator. 
This notion of "faking good," or over-rep011ing desirable and virtuous qualities is a 
common psychological effect of completing any psychological diagnostic instrument. 
Psychologists understand, as agents of change themselves, that they can evoke 
eounterintuitive or contraindicated behavior in their patients. In psychological terms this 
may be called debasement, desirability, conformity, obedience to authority, 
overconfidence or, in some cases properly named, the Hawthorne effect. If psychologists 
are willing to understand, and subsequently admit this type of influence pursuant to their 
interventions, it stands to reason physicians, including their interventions, will have 
similar, if not identical influences. 
The findings of this study are interesting because they offer support for some 
hypotheses, and also reveal new insights beyond the intended scope of this study. Of 
most notable concern, the findings did provide support for the hypothesis proposing that 
individuals who experience an improvement in cholesterol levels after taking statin 
medications begin to rcduce their adherence to healthy dietary habits (see Table 6). This 
finding can lead to a number of speculations regarding how individuals think about the 
positive effects of cholesterol-lowering medications. One possible explanation may 
suggest that individuals on statin therapy who experience a significant drop in total 
cholesterol levels and rapid improvement in lipid profiles may provide an impetus for 
patient behavior to "regress to the mean." That is, it is plausible to suspect in the absence 
of clear and convincing genetic evidence, that overeating, diet non-adherence, and the 
excessive consumption of foods rich in trans-fatty acids are causally indicated in elevated 
cholesterol levels. It therefore stands to reason that if diet non-adherence was the 
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normative behavior before cholesterol medication, behavioral regression toward the mean 
can explain some of the active diet non-adherence seen in participants who are on statin 
therapy. Another possible explanation includes the phenomenon of overconfidence. The 
data in this study reveal no significant difference between taking statin medication and 
overconfidence, but other data including the prevalence of overweight and obese 
paliicipants seems to provide evidence for some other factor moderating diet and exercise 
non-adherence, possibly denial or apathy. However, overconfidence should not be 
overlooked in future studies of similar interest. That is, social psychology purports the 
overconfidence effect is a tendency for humans to be more confident about personal 
beliefs, abilities, and behaviors than are actually accurate. With respect to statin therapy 
and exercise non-adherence, overconfidence may result from reviewing the diminished 
laboratory levels of total cholesterol, thereby creating a tendency to predict, or 
overestimate the conective power of the medication and underestimate the need to 
remain faithful to a healthy diet. The danger in this thinking may expose patients to an 
inadequate understanding of total semm cholesterol as not being necessarily the best 
reading of elevated lipids in the bloodstream. Together, high density lipoproteins, low 
density lipoproteins, and triglicerides and their ratio to each other represent more accurate 
lipid levels in the blood. Although total cholesterol may be reduced by significant 
percentages, the appropriate ratios ofHDL's to LDL's to triglycerides may continue to be 
misaligned. However, the initial interpretation of the reduced total cholesterol number 
may provide enough evidence for some patients to non-adhere to healthful diets. Again, 
although there was no statistical evidence for overconfidence in statin medication as a 
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predictor of diet and exercise non-adherence, future researchers are encouraged to gather 
a larger, more representative sample size. 
Another discovery of this study revealed no significant difference found in the 
amount of cardiovascular exercise practiced before beginning statin therapy and 
concurrent with statin therapy (see Figure 10 and 11). However, a serendipitous 
discovery revealed, a related, but discouraging finding. Results indicate that individual 
personal health-related beliefs about the causes of high cholesterol were negatively 
correlated at the 0.01 level of significance (-.397**) with the practice of cardiovascular 
exercise three times a week or more. For example, participants who agreed with the 
statement "I believe my cholesterol is caused by poor diet" were then likely to disagree 
with the following variable: "Since I have been taking cholesterol lowering medicine, I 
practice cardiovascular exercise three times a week or more." Interestingly, this finding 
is in stark contrast to CUlTent medical beliefs. Also, data indicate individual personal 
health beliefs about the lack of exercise causing elevated cholesterol were negatively 
cOlTelated at the 0.01 level of significance (-.422**) with the practice of cardiovascular 
exercise three times a week or more. Stated otherwise, paIiicipants who agreed with the 
variable "I believe my cholesterol is caused by the lack of exercise" disagreed with the 
variable "Since I have been taking cholesterol lowering medicine, I practice 
cardiovascular exercise three times a week or more." Considering both negative 
cOlTelations in light of the data in presented in Table 6, it would appear that paIiicipants 
understand that genetic heritage is not entirely responsible for elevated cholesterol levels, 
and that diet and exercise are effective ways to reduce it, but they appear unwilling to 
change their lifestyles. Although this finding is not consistent with the construct of 
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overconfidence, it may suggest a level of indifference or apathy regarding the use of 
exercise and diet to control cholesterol. Again, these findings are in contrast to the 
current medical belief, in which physicians are advised to educate their patients on the 
benefits of exercise and a healthful diet. 
Limitations of the Study 
The results of this study should be interpreted in light of several potential 
limitations. Generally, rating scale and survey data can be biased and be influenced by a 
number of factors. Influences including the wording of statements, arrangement of 
statements, and the content of the material itself may influence the subject to interpret the 
statement differently. Also, in studies that employ surveys, questionnaires, or rating 
scales, the subject may be motivated to respond in a fashion that is more socially 
acceptable than are their true attitudes, beliefs, and behaviors. Although the statements 
for the present study were designed to elicit agreement on a Likert scale and were created 
in a fashion that was free of bias and of non-leading statements, survey data in general 
are subject more frequently to the abovementioned methodological limitations. 
Another foreseeable limitation of the cunent study includes the sample size and 
population selected to paliicipate in the study. Although every effOli was made to ensure 
a wide range of randomly selected participants, the samples were procured from a 
particular geographic location, eastern Pennsylvania. This may provide an under-
representation of various cultural and racial demographics. This poses a common and 
general threat to the external validity of the study. The sample was biased for female 
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paliicipants, and a larger sample size may have counterbalanced this unforeseen 
tendency. 
Also, the number of questions used in this study may have produce fatigue in 
participants and caused them to respond randomly or in a hasty fashion. This was 
evidenced by several incomplete surveys which needed to be discarded. The pace in 
primary care medicine tends to be quick; a more focused survey with fewer items may 
have been more expedient and quite possibly have influenced the results. 
Last, the ANOV A used in hypothesis three did reveal statistical significance for a 
negative change in healthy dietary habits following all improvement in cholesterol levels 
pursuant to medication; however, the significance was small. A greater sample size may 
help boost the power of this study and yield more favorable significance. 
Implicationsfor Clinical Practice and Future Research 
Although many factors will influence an individual's belief system about 
medications, disease, and health-related behavior, the hypotheses for this study did 
elucidate a number of implications regal"ding clinical practice. Initially, improvements in 
the quantity and quality of physician education regarding the limitations of statin 
medication can be adjusted accordingly, and simultaneous patient education regarding the 
benefits of diet and exercise adherence can be further strengthened. Also, physicians can 
fbrther benefit from the knowledge revealed in this study by becoming familiar with the 
limitations of patient compliance and adjust their educational strategies in a more clearly 
focused and direct fashion when presenting infol1uation to patients. 
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Future researchers are encouraged to consider the methodological limitations of 
this study and replicate future studies in light of the results provided herein. Continuing 
to study overconfidence and the effects that it projects on health-related behaviors 
continues to be an important construct, because overconfidence has been a well 
established phenomenon in other areas of psychology. Developing fewer and more direct 
statements to this population may yield favorable results. Also, expanding the sample 
size may prove to be a prudent measure for future studies. 
Conclusion 
There is statistical evidence available to support the hypothesis that when statin 
medicines improve cholesterol levels, and when improved levels are noticed, there is a 
statistically signifIcant reduction in the adherence to healthy diet habits. Also, 
participants appear to understand that genetics is not the only reason for elevated 
cholesterol levels, with diet and exercise as reasonable ways to control for elevated 
cholesterol. However, they do not adjust their lifestyles. 
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APPENDIX A 
Dear Potential Participant: 
Barbara Golden, Psy.D., ABPP and Stephen Timchack, M.S. both of the 
Philadelphia College of Osteopathic Medicine (PCOM) are conducting a research 
study on people's thoughts regarding cholesterol-lowering medicines. 
This study has been designed to maintain your privacy, and no one will be able 
to find out who you are, or identify you from the answers that you report. You 
will not be asked to provide any personal information. The questionnaires are 
completely anonymous, but will be numbered to keep order if the packet 
becomes unstapled. You will be asked to answer some basic questions and 
mark your level of agreement with several statements regarding your diet 
habits, health beliefs, and exercise frequency. It will take 15-20 minutes of 
your time. If you agree to participate in this study, we ask that you fill out all 
forms completely, and simply return them to the nurse or receptionist. You 
may freely refuse to be in this study with absolutely no consequences. You can 
decide to stop answering the survey at any time. Although, no personal 
information will be asked, all the forms and questionnaires that you complete 
will be kept secure and confidentiaL Only the researchers and members of the 
Institutional Review Board at PCOM will be able to look at these records. 
You will not receive any financial reimbursements for being in this research 
study. You may not benefit directly from being in this research study. 
However, other people in the future may benefit from what researchers learn 
from this study. There is a possibility that you may, as a result of filling out the 
questionnaires, find something out about yourself that may be potentially 
distressing; however, this outcome is unlikely. 
If you believe that you have suffered injury or illness during the course of this 
study, you should contact the PCOM Office of Research and Sponsored 
Programs at 215-871-6782. 
If you have any questions about this research at any time, you can contact Dr. 
Golden at (215) 871-6495. If you want to know more about Dr. Golden's 
background, or the rights of research participants, you should call PCOM Office 
of Research and Sponsored Programs at 215-871-6782. 
Thank you very much for your time, help, and consideration in this study. 
Sincerely, 
Barbara A. Golden, Psy.D, ABPP 
Associate Professor 
Psychology 
(215) 871-6511 
Stephen M. Timchack, M.S. 
Doctoral Candidate in Clinical 
(570) 466-7015 
Statin Effects 70 
APPENDIXB 
Demographic Survey 
1. Has your physician diagnosed you with High Cholesterol? 
a. YES 
b. NO (if "NO" stop here and return survey) 
2. If you are diagnosed with High Cholesterol, how long have 
you had this condition? 
a. Less than 1 year 
b. 1-3 years 
c. 4-6 years 
d. 7-9 years 
e. Over 10 years 
f. Not applicable/don't know 
3. Are you currently taking prescription tnedication(s) to help 
control High Cholesterol? 
a. Yes 
b. No 
4. If you are not taking prescription medicine(s) for high 
cholesterol, do you follow a low-fat diet? 
a. Yes 
b. No 
c. Not applicable 
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5. What type of cholesterol nledication are you taking? 
a. ZOCOR 
b. LIPITOR 
c. CRESTOR 
d. VYTORIN 
e. OTHER: 
--------------------
f. I do not know the name of my cholesterol medicine 
g. I am not taking any medicines for high cholesterol 
6. What is the dosage of your cholesterol nledication? 
a. 10 nlg. 
b. 20 mg 
c. 30 mg. 
d. 40 mg 
e. Other: 
------------------------
f. I am not taking any nledicines for high cholesterol 
g. I do not know the dose 
7. How long have you been on this medicine? 
a. 1 year or less 
b. 2-4 years 
c. 5-7 years 
d. 8-10 years 
e. more than 10 years 
f. not applicable 
8. Are you: 
a. MALE 
b. FEMALE 
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9. Are you: 
a. Black 
b. White 
c. Asian 
d. Hispanic 
e. Other: 
10. How old are you? 
a. 18-25 
b. 26-35 
c. 36-45 
d. 46-55 
e. 56-65 
f. 66 or older 
11. How often do you practice cardiovascular exercise (for 
example, brisk walking or running)? 
a. more than 3 tin1es weekly 
b. 3 tilnes weekly 
c. less than.3 tilnes weekly 
d. I rarely practice cardiovascular training 
12.What is your current weight? ~_~" ___ _ 
13.How tall are you (in feet and inches)?_" 
14.Do you follow a physician prescribed exercise progra111? 
a. Yes, I follow it very closely 
b. Yes, I follow it most of the time 
c. No, I rarely follow it 
d. No, I don't have a physician prescribed exercise 
progran1 
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I5.Do you follow a low-cholesterol (low fat) diet? 
a. Yes, I follow my diet daily and honestly 
b. Yes, I follow my diet, but sometimes I cheat 
c. No, I don't usually follow a low fat diet 
d. No, I don't Inlow what a low fat diet is 
I6.High Cholesterol, that is untreated, may lead to which of the 
following: 
a. Heart attack and/or stroke 
b. Depression 
c. Anxiety 
d. Gout 
e. Stomach Ulcers 
I 7.High Cholesterol can come from: 
a. The foods I eat 
b. My genetics (family history) 
c. Getting too little physical exercise 
d. All of the above 
I8.Since I have been taking cholesterol-lowering medicine, my 
physician has been with my cholesterol level. 
a. very satisfied 
b. satisfied 
c. very concerned 
d. concerned 
I9.My physician has told me that my cholesterol levels 
have since I have been on cholesterol-lowering 
nledicine. 
a. improved 
b.· worsened 
c. stayed the sanle 
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20.Since I began taking cholesterol-lowering medicine, my 
physician has the dose of my cholesterol-
lowering medicine. 
a. increased 
b. decreased 
c. not changed 
21. Which level of education best describes you: 
a. Attended high school 
b. Graduated high school 
c. Some college 
d. Graduated college 
e. Attended graduate school 
f. Graduated from graduate school 
22. Which occupational category best describes your CUlTent 
emploYlnent status: 
a. Retired 
b. Student 
c. Management, Business or Financial 
d. Science, Engineering or Computing 
e. Healthcare PractitionerlProfessional 
f. Other Professional 
g. Technician 
h. Sales 
i. Adlninistrative Support 
j. Construction or Trade Worker 
k. Installation, Maintenance or Repair Worker 
L Production or Manufacturing 
m. Transportation 
n. Laborer 
o. Protective/Civil Service Worker 
p. Other 
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APPENDIXC 
Survey of Health-Related Beliefs and Behaviors 
DESCRIPTION: The following statements were designed to 
understand your eating and exercise behaviors, as well as your health-
related beliefs. Please consider each statement carefully and answer 
honestly. If you are completely confused by a question or are 
completely unsure how you feel, please shnply circle 3. There are 
statements on both sides of the page, please do not skip any. 
Please use the following scale to indicate your level of agreenlent 
with each statement. 
1. Since I've been taking cholesterol-lowering medicine, I can 
eat anything I want. 
1 2 3 4 5 
2. Since I've been taking cholesterol-lowering medicine, I 
watch the pOliion size of Iny food servings. 
1 2 3 4 5 
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3. I believe my cholesterol-lowering ll1edicine, without diet and 
exercise, completely protects me from developing higher 
cholesterol levels. 
1 2 3 4 5 
4. Since I take cholesterol-lowering medicine, exercising is not 
that important. 
1 2 3 4 5 
5. Since I have been taking cholesterol-lowering medicine, I 
feel less won-ied about choosing what I eat. 
1 2 3 4 5 
6. Since I have been taking the cholesterol-lowering medicine, I 
eat "red" meat nlore than twice a week. 
1 2 3 4 5 
7. Since I have been taking cholesterol-lowering lTIedicine, I eat 
lTIOre than three servings of dairy products daily. 
1 2 3 4 5 
8. Before I began taking cholesterol-lowering medicine, I ate 
"red" meat more than twice a week. 
1 2 3 4 5 
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9. Taking cholesterol-lowering medicine regularly is nlore 
important than Inaintaining a healthy diet. 
1 2 3 4 5 
10. Taking cholesterol-lowering nledicine regularly is more 
important than exercise. 
1 2 3 4 5 
11. Since I take cholesterol-lowering medicine I can eat "fast 
food" 2 or more tilnes a week. 
1 2 3 4 5 
12.Since I have been taking cholesterol-lowering nledicine, I 
practice cardiovascular exercise 3 times a week or more. 
1 2 3 4 5 
13.1 believe my Doctor has prescribed a reasonable diet and 
exercise plan for me. 
1 2 3 4 5 
14. I am taking cholesterol-lowering medicine to prevent the 
possibility of a heart attack and/or stroke. 
1 2 3 4 5 
15. I trust the cholesterol-lowering nledicine I anl taking will 
effectively lower my cholesterol without diet and exercise. 
1 2 3 4 5 
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16. If my cholesterol level continues to remain high while on 
cholesterol-lowering medicine, I can have my dosage increased 
and continue eating any of the foods I choose. 
1 2 3 4 5 
17. High Cholesterol COlnes entirely from genetics--diet and 
exercise are not effective ways to reduce it. 
1 2 3 4 5 
18. Before I began taking cholesterol-lowering medicine, I ate 
nlore than 3 servings of dairy product daily. 
1 2 3 4 5 
19. CUlTently, I eat five, or lnore, servings of fruits and 
vegetables daily. 
1 2 3 4 5 
20. My Doctor has done a goodjob at educating me about the 
dangers of High Cholesterol. 
1 2 3 4 5 
21. Taking cholesterol-lowering medicine allows me to 
occasionally eat fattening food and over indulge. 
1 2 3 4 5 
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22. A healthy diet consists of plenty of flUits and vegetables, 
whole grains, fish, and limited use of fats, processed 
sugars, salt, and alcohol. 
1 2 3 4 5 
23. A healthy lifestyle consists of healthy eating, non-slnoking, 
getting plenty of exercise, good sleep habits, good stress 
Inanagement skills, and managing a healthy weight. 
1 2 3 4 5 
24. As described above, I have a healthy diet. 
1 2 3 4 5 
25. As described above, I have a healthy lifestyle. 
1 2 3 4 5 
26. Before I began taking cholesterol-lowering medicine, I ate 
"fast food" 2 or more tilnes a week. 
1 2 3 4 5 
27. Before I began taking cholesterol-lowering Inedicine, I ate 
Inore than 5 servings of fruits and vegetables daily. 
1 2 3 4 5 
28. Cunently, I eat "red" meat more than twice a week. 
1 2 3 4 5 
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29. Before I began taking cholesterol-lowering medicine, I was 
not won-ied about nly diet. 
1 2 3 4 5 
30. Before I began taking cholesterol-lowering medicine, I 
practiced cardiovascular exercise 3 times a week (for at 
least 30 minutes) or more. 
1 2 3 4 5 
31. Before I began taking cholesterol-lowering medicine, I 
watched the pOliion size of my food servings. 
1 2 3 4 5 
32. If I take care oflnyself, I can avoid illness. 
1 2 3 4 5 
33. Whenever I get sick it is because of something I've done or 
not done. 
1 2 3 4 5 
34. Good health is largely a matter of good fortune. 
1 2 3 4 5 
35. No nlatter what I do, if I anl going to get sick I will get sick. 
1 2 3 4 5 
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36. Most people do not realize the extent to which their 
illnesses are controlled by accidental happenings. 
I 2 3 4 5 
37. I can only do what my doctor tells me to do. 
1 2 3 4 5 
38. There are so many strange diseases around that you can 
never know how or when you might pick one up. 
1 2 3 4 5 
39. When I feel ill, I lmow it's because I have not been getting 
the proper exercise or eating right. 
1 2 3 4 5 
40. People who never get sick are just plain lucky. 
1 2 3 4 5 
41. People's ill health results froln their own carelessness. 
1 2 3 4 5 
42. I am directly responsible for my health. 
1 2 3 4 5 
43. I believe Iny high cholesterol is caused by genetics 
I 2 3 4 5 
44. I believe my cholesterol is caused by poor diet 
I 2 3 4 5 
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45. I believe my high cholesterol is caused by the lack of 
exerClse. 
1 2 3 4 5 
